Hexagon Capital Partners LLC reduced its holdings in The Clorox Company (NYSE:CLX – Get Rating) by 22.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 381 shares of the company's stock after selling 109 shares during the quarter. Hexagon Capital Partners LLC's holdings in Clorox were worth $53,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. grew its position in shares of Clorox by 1.3% in the first quarter. Vanguard Group Inc. now owns 14,685,046 shares of the company's stock valued at $2,041,661,000 after purchasing an additional 185,012 shares during the last quarter. BlackRock Inc. lifted its stake in shares of Clorox by 5.6% in the third quarter. BlackRock Inc. now owns 10,964,049 shares of the company's stock valued at $1,407,673,000 after buying an additional 580,982 shares during the period. State Street Corp lifted its stake in shares of Clorox by 9.6% in the second quarter. State Street Corp now owns 8,907,083 shares of the company's stock valued at $1,255,721,000 after buying an additional 778,269 shares during the period. Wells Fargo & Company MN lifted its stake in shares of Clorox by 2.4% in the second quarter. Wells Fargo & Company MN now owns 3,557,161 shares of the company's stock valued at $501,489,000 after buying an additional 82,698 shares during the period. Finally, Federated Hermes Inc. lifted its stake in shares of Clorox by 11.1% in the third quarter. Federated Hermes Inc. now owns 2,161,323 shares of the company's stock valued at $277,492,000 after buying an additional 215,425 shares during the period. 79.12% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Performance

NYSE CLX opened at $154.61 on Friday. The firm has a market cap of $19.10 billion, a price-to-earnings ratio of 44.17, a PEG ratio of 3.16 and a beta of 0.29. The company has a 50 day moving average of $150.33 and a 200-day moving average of $144.84. The company has a current ratio of 0.86, a quick ratio of 0.47 and a debt-to-equity ratio of 5.04. The Clorox Company has a 1-year low of $120.50 and a 1-year high of $160.59.

Clorox (NYSE:CLX – Get Rating) last posted its quarterly earnings data on Thursday, February 2nd. The company reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.66 by $0.32. The company had revenue of $1.72 billion during the quarter, compared to analyst estimates of $1.66 billion. Clorox had a net margin of 6.16% and a return on equity of 89.97%. The company's revenue was up 1.4% on a year-over-year basis. During the same quarter last year, the business posted $0.66 earnings per share. On average, equities analysts forecast that The Clorox Company will post 4.23 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 12th. Investors of record on Wednesday, April 26th will be issued a $1.18 dividend. This represents a $4.72 dividend on an annualized basis and a dividend yield of 3.05%. The ex-dividend date of this dividend is Tuesday, April 25th. Clorox's dividend payout ratio is currently 134.86%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. StockNews.com assumed coverage on shares of Clorox in a research note on Thursday, March 16th. They issued a "hold" rating for the company. Morgan Stanley increased their target price on shares of Clorox from $142.00 to $145.00 and gave the company an "equal weight" rating in a research note on Friday, February 3rd. Barclays reduced their target price on shares of Clorox from $110.00 to $108.00 and set an "underweight" rating for the company in a research note on Monday, February 6th. Jefferies Financial Group raised their price target on shares of Clorox from $140.00 to $145.00 and gave the stock a "hold" rating in a research note on Wednesday, February 1st. Finally, Deutsche Bank Aktiengesellschaft cut their price target on shares of Clorox from $152.00 to $147.00 in a research note on Monday. Seven equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, Clorox currently has a consensus rating of "Hold" and a consensus price target of $141.00.

Clorox Company Profile

(Get Rating)

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.

Recommended Stories

• Get a free copy of the StockNews.com research report on Clorox (CLX)
• KB Home Strong Results Lift Prices
• Chewy Stock Is Setting Up For Long-Term Profitable Growth
• Why Wall Street Loves These 3 Penny Stocks
• Carvana May Be Able To Reach Profitability This Year
• Low Volume Bunge Plunge Presents an Opportunity

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.